LC Sciences

Executive Summary

LC Sciences is a US-based biotechnology company established in 2000, headquartered in Houston, Texas. The company provides high-throughput sequencing and multi-omics services, including genomics, transcriptomics, epigenomics, and proteomics, to research institutions globally. Leveraging advanced platforms such as Illumina sequencers and 10x Genomics systems, LC Sciences delivers comprehensive data and bioinformatics support. As a privately held firm with over two decades of operational history, it has built a reputation for reliability and technical expertise in the competitive genomics service market. The company's broad service portfolio and established client base position it as a steady player in the life sciences tools sector, though visibility into financials and growth trajectory is limited due to its private status. Key drivers include ongoing demand for multi-omics research and the expansion of precision medicine, which could fuel future service adoption.

Upcoming Catalysts (preview)

• Q3 2026Launch of Single-Cell Multi-Omics Service60% success
• Q4 2026Strategic Partnership with a Major Pharmaceutical Company50% success
• Q2 2026Expansion of Bioinformatics Analysis Suite70% success